Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Entero Therapeutics (GRDX)

Annual Return

Over the past 3 years, GRDX has had an average annual return of +0%, underperforming the benchmark SPY, which returned +19.62% annual.

Over the past 5 years, GRDX has had an average annual return of -97.24%, underperforming the benchmark SPY, which returned +12.73% annual.

Since Oct 11, 2016, GRDX has had an average annual return of -74.16%, underperforming the benchmark SPY, which returned +15.51% annual.

20232022202120202019201820172016
-83.33%-97.93%-85.11%-6.70%-14.07%-66.73%-23.27%-4.82%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2023-16.67%-40.00%+0%+0%-33.33%+0%-50.00%-83.33%
2022-11.38%-7.39%-10.50%-41.78%-43.55%-42.86%-25.00%-30.00%-52.38%-30.00%-14.29%+0%-97.93%
2021+50.51%-1.36%-6.95%-31.74%-7.08%-3.51%-33.70%+15.66%-55.34%-8.87%-19.84%-29.61%-85.11%
2020-9.00%-13.00%-29.52%+8.58%+27.43%+12.84%+7.04%-15.41%-13.30%+2.24%+9.25%+22.13%-6.70%
2019+74.61%-2.03%+16.89%+2.49%-11.69%-22.37%-40.60%-0.99%-39.99%+9.46%+0.45%+57.58%-14.07%
2018-1.29%-27.58%+20.76%-9.90%-14.10%+32.09%-20.57%+9.80%-8.20%-14.01%-11.76%-37.95%-66.73%
2017-7.60%-5.25%-7.01%+1.06%-10.00%+14.53%+9.20%-15.71%+7.83%-20.81%+2.22%+12.60%-23.27%

Drawdown analysis of Entero Therapeutics (GRDX)

The maximum drawdown for the GRDX was -99.99%, occurring on Jun 8, 2023. This drawdown has not yet recovered.

The current GRDX drawdown is -99.99%.

Since Oct 11, 2016 GRDX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Oct 12, 20161674Jun 8, 2023OngoingOngoingOngoing